Neurocysticercosis Presenting as Migraine in the United States.


Journal

The American journal of case reports
ISSN: 1941-5923
Titre abrégé: Am J Case Rep
Pays: United States
ID NLM: 101489566

Informations de publication

Date de publication:
07 Mar 2024
Historique:
medline: 7 3 2024
pubmed: 7 3 2024
entrez: 7 3 2024
Statut: epublish

Résumé

BACKGROUND Cysticercosis is a condition caused by infection with the larval form of Taenia solium, a pork tapeworm that uses pigs as an intermediate host. Humans become infected when they ingest water or food contaminated with tapeworm cysts. Cysticercosis is increasing in frequency in developed countries due to increased access to travel. Neurocysticercosis occurs when Taenia solium cysts embed within the nervous system. The clinical presentation of neurocysticercosis ranges from asymptomatic to life-threatening, largely depending on the brain parenchymal involvement. The diagnosis is typically made with a combination of clinical evaluation, serology, and neuroimaging. Treatment for parenchymal neurocysticercosis may involve anthelmintic agents, symptomatic agents, surgery, or a combination of methods. CASE REPORT A 52-year-old man with a medical history of migraine headaches, complicated type 2 diabetes mellitus, and obesity presented with a 4-month change in his migraines becoming severe, worse over his occiput bilaterally, and unresponsive to abortive therapy. His exposure history was unremarkable except for a habit of eating undercooked bacon, by which he would have developed neurocysticercosis via autoinfection. Neuroimaging and serology confirmed a diagnosis of neurocysticercosis and he was treated accordingly with antiparasitic and anti-inflammatory medications. CONCLUSIONS This presentation is nonspecific and can easily be overlooked, especially if there is an underlying known neurological condition such as migraine. This case illustrates that neurocysticercosis should be considered when an existing neuropathological condition displays a change in presentation or requires a change in therapeutic management, even without obvious risk factors.

Identifiants

pubmed: 38449298
pii: 943133
doi: 10.12659/AJCR.943133
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e943133

Auteurs

Eamonn Byrnes (E)

Department of Internal Medicine, Orlando Regional Medical Center, Orlando, FL, USA.

Brian Shaw (B)

Department of Internal Medicine, Orlando Regional Healthcare System, Orlando, FL, USA.

Ryan Shaw (R)

Department of Biomedical Sciences, University of South Florida, Tampa, FL, USA.

Mario Madruga (M)

Department of Internal Medicine, Orlando Regional Healthcare System, Orlando, FL, USA.

Stephen J Carlan (SJ)

Division of Academic Affairs and Research, Orlando Regional Healthcare System, Orlando, FL, USA.

Classifications MeSH